Higher amoebic and metronidazole resistant forms of Blastocystis sp. seen in schizophrenic patients

Freddy Franklin1,2, Arutchelvan Rajamanikam1,2, Chandramathi Samudi Raju2

  • 1Department of Parasitology, Universiti Malaya (UM), Kuala Lumpur, 50603, Malaysia.

Parasites & Vectors
|September 5, 2022
PubMed
Abstract

Insights

Blastocystis sp. in schizophrenia patients exhibits altered growth, morphology, and drug resistance compared to non-schizophrenic individuals. These findings suggest the gut environment influences Blastocystis sp. phenotypes.

Area of Science:

  • Medical Microbiology
  • Human Gut Microbiome Research
  • Schizophrenia Pathogenesis

Background:

  • Blastocystis sp. is a common human gut commensal with known interactions with gut bacteria.
  • Previous studies suggest Blastocystis sp. can be pathogenic and is prevalent in schizophrenia patients.
  • Phenotypic characteristics of Blastocystis sp. in schizophrenia patients remain undescribed.

Purpose of the Study:

  • To investigate the genotypic and phenotypic characteristics of Blastocystis sp. isolated from individuals with schizophrenia (SZ).
  • To compare the phenotype of Blastocystis sp. from SZ patients with that from non-schizophrenic (NS) individuals.

Main Methods:

  • Faecal samples from 50 SZ and 100 NS individuals were screened for Blastocystis sp. using culture and PCR.
  • Positive isolates underwent genotypic (subtype analysis) and phenotypic characterization.
  • Phenotypic analyses included growth rate, cell morphology, drug resistance, cell surface glycoprotein expression, and protease activity.

Main Results:

  • Blastocystis sp. was detected in 24% of SZ individuals and 5% of NS individuals.
  • ST3 was the most prevalent subtype (66.7%) in SZ patients.
  • Isolates from SZ individuals showed slower growth, larger cell diameter, increased amoebic forms, metronidazole resistance, higher Concanavalin A binding, and elevated cysteine and serine protease levels compared to NS isolates.

Conclusions:

  • Blastocystis sp. from SZ patients exhibits distinct phenotypic variations, including altered morphology and drug resistance.
  • The gut environment in schizophrenia and potential treatments may influence Blastocystis sp. phenotype.
  • Further research is needed to elucidate the clinical implications of these phenotypic changes.

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
97
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
906
Diversity of Protists II01:27

Diversity of Protists II

Alveolates are a group of organisms recognized by the presence of alveoli, which are cytoplasmic sacs located beneath the cell membrane. While their function remains uncertain, alveoli may help regulate water balance by controlling how much water enters and leaves the cell. In dinoflagellates, these structures may serve as armor plates. There are three major types of alveolates: ciliates, which move using cilia; dinoflagellates, which use flagella for movement; and apicomplexans, which are...
112
Diversity of Protists I01:15

Diversity of Protists I

Excavata is a diverse group of protists that includes both chemoorganotrophic and phototrophic species, with some thriving in anaerobic environments. Among the key groups within Excavata are diplomonads and parabasalids, which are flagellated protists that lack mitochondria and chloroplasts. These microorganisms typically inhabit anoxic environments, such as the intestines of animals, where they exist either symbiotically or as parasites, relying on fermentation for energy production. Some...
100
Diversity of Protists IV01:27

Diversity of Protists IV

Amoebozoa represent a diverse group of terrestrial and aquatic protists that utilize lobe-shaped pseudopodia for locomotion and feeding. This characteristic differentiates them from the Rhizaria, which possess threadlike pseudopodia. The primary classifications within Amoebozoa include gymnamoebas, entamoebas, and the plasmodial and cellular slime molds. Phylogenetic evidence indicates that Amoebozoa diverged from a lineage that ultimately gave rise to fungi and animals.Gymnamoebas and...
104
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
200